When should stool be described as fat in the stool versus steatorrhea?

When to Describe Stool as "Fat in Stool" vs "Steatorrhea"

Steatorrhea is the formal clinical term that should be used when fecal fat excretion exceeds 7% of ingested fat (coefficient of fat absorption <93%), which typically corresponds to >7 grams of fat per day in stool, while "fat in the stool" is an imprecise descriptive term that lacks diagnostic specificity.

Defining Steatorrhea

The term "steatorrhea" has a specific clinical definition based on quantitative measurements 1:

• Formal definition: Coefficient of fat absorption <93% (meaning >7% of ingested fat appears in stool)
• Quantitative threshold: Fecal fat excretion >7 g/day on a standardized diet
• Severe steatorrhea: Fecal fat excretion >13 g/day (47 mmol/day), most commonly seen in pancreatic exocrine insufficiency 2

Clinical Recognition

Visible steatorrhea requires moderate dietary fat intake to become apparent 1. The clinical features that distinguish true steatorrhea include 1:

• Bulky, greasy, foul-smelling stools
• Stools that float or are difficult to flush
• Oily residue in toilet water
• Associated symptoms: weight loss, bloating, excessive flatulence
• Fat-soluble vitamin deficiencies (A, D, E, K)

Important Caveat on Visual Assessment

While experienced clinicians can identify steatorrhea visually with 89.3% sensitivity and 91.1% specificity when considering fecal output >200 g/day, appearance, and odor 3, clinical assessment by stool inspection alone is unreliable 2. Visual observation should prompt formal testing, not replace it.

When to Use Each Term

Use "Steatorrhea" when:

1. Quantitative testing confirms fecal fat >7 g/day or coefficient of fat absorption <93%
2. Fecal elastase <100 mg/g strongly suggests exocrine pancreatic insufficiency with associated fat malabsorption 1
3. Clinical syndrome is present: The patient has characteristic symptoms (bulky, greasy stools) plus weight loss, nutritional deficiencies, or high-risk conditions (chronic pancreatitis, pancreatic cancer, cystic fibrosis, post-pancreatic surgery) 1

Use "Fat in Stool" (descriptive only) when:

1. Patient reports oily or greasy-appearing stools but no formal testing has been performed
2. Describing a clinical observation that requires further evaluation
3. This term should prompt diagnostic workup, not serve as a final diagnosis

Diagnostic Approach

When steatorrhea is suspected 1:

1. First-line test: Fecal elastase on semi-solid or solid stool specimen

   • <100 mg/g = good evidence of EPI
   • 100-200 mg/g = indeterminate
   • Can be performed while on pancreatic enzyme replacement therapy

2. Fecal fat testing (rarely needed in routine practice):

   • Requires high-fat diet (typically 100 g/day for 5 days)
   • 72-hour stool collection during final 3 days
   • Quantitative testing is burdensome and generally not practical 1
   • Consider only when clinical features are inconclusive or assessing inadequate response to treatment

3. Sudan stain: Nonspecific for EPI and not recommended as definitive test 1

Common Pitfall

Do not use "response to pancreatic enzyme therapy" as a diagnostic test 1. Patients with nonspecific symptoms (bloating, gas, foul-smelling stools) may improve on pancreatic enzymes due to placebo effect or masking of other disorders like celiac disease, leading to diagnostic delays. Appropriate testing (fecal elastase) should be performed before initiating therapy.

Clinical Significance

The distinction matters because untreated steatorrhea from exocrine pancreatic insufficiency leads to complications from fat malabsorption and malnutrition, negatively impacting quality of life 1. Proper diagnosis enables appropriate pancreatic enzyme replacement therapy (minimum 40,000 USP units of lipase per meal in adults) and monitoring of nutritional status, fat-soluble vitamins, and bone density 1.